Seven members of Congress have written to OMB, sharing the same concerns we have about FDA's MOU on interstate shipments of compounded drugs: As written, it will place a tremendous and undue burden on state boards of pharmacy. Read the letter at https://a4pc.org/Common/Uploaded files/Advocacy/2020-06-08_Letter-to-OMB-on-MOU.pdf